Los estudios han validado su eficacia, no solo en la reduccin del peso corporal, sino tambin en la mejora de varios parmetros metablicos, lo que los hace particularmente valiosos para pacientes con obesidad y comorbilidades como la diabetes tipo 2, el sndrome metablico y la incapacidad por el control diettico en pautas hipocalricas
In addition, MS is associated with the development of neurodegeneration result in cognitive impairment (Al-kuraishy et al
This suggests that some therapeutic benefits of canagliflozin could result from the activation of AMPK, rather than inhibition of SGLT2 ( DPP-4 inhibitors These compounds, by preventing deactivation by dipeptidyl peptidase-4 (DPP4) inhibitors, improve the concentration of endogenous incretins (Vangoitsenhoven et al., 2012)
[57] Consequently, this lowers the systemic release of inflammatory cytokines like IL-6 and TNF-
Semaglutide and tirzepatide are groundbreaking medications for type 2 diabetes and weight loss